NasdaqGS - Delayed Quote • USD
Hologic, Inc. (HOLX)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:17 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 17 | 17 |
| Avg. Estimate | 0.98 | 1.02 | 4.03 | 4.39 |
| Low Estimate | 0.96 | 0.99 | 3.97 | 4.18 |
| High Estimate | 1 | 1.05 | 4.07 | 4.55 |
| Year Ago EPS | 1.06 | 0.93 | 3.96 | 4.03 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 17 | 17 |
| Avg. Estimate | 1B | 1.01B | 4.03B | 4.25B |
| Low Estimate | 997.56M | 995M | 3.99B | 4.11B |
| High Estimate | 1.01B | 1.02B | 4.04B | 4.32B |
| Year Ago Sales | -- | -- | 4.03B | 4.03B |
| Sales Growth (year/est) | -- | -- | 0.00% | 5.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.88 | 0.89 | 0.84 | 0.95 |
| EPS Actual | 1.06 | 0.93 | 0.89 | 0.98 |
| Difference | 0.18 | 0.04 | 0.05 | 0.03 |
| Surprise % | 20.50% | 4.50% | 6.00% | 3.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.98 | 1.02 | 4.03 | 4.39 |
| 7 Days Ago | 0.98 | 1.02 | 4.03 | 4.39 |
| 30 Days Ago | 0.98 | 1.02 | 4.03 | 4.39 |
| 60 Days Ago | 0.98 | 1.02 | 4.03 | 4.39 |
| 90 Days Ago | 0.98 | 1.02 | 3.99 | 4.33 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | HOLX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -7.50% | -- | -- | 1.60% |
| Next Qtr. | 9.70% | -- | -- | 10.50% |
| Current Year | 1.80% | -- | -- | 5.20% |
| Next Year | 8.90% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 7.40% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 11.38% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/10/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/4/2024 |
| Upgrade | Citigroup: Neutral to Buy | 4/3/2024 |
| Maintains | UBS: Neutral to Neutral | 2/2/2024 |
| Maintains | Raymond James: Outperform to Outperform | 2/2/2024 |
| Maintains | Needham: Buy to Buy | 2/2/2024 |
Related Tickers
RGEN Repligen Corporation
157.14
+0.05%
TFX Teleflex Incorporated
206.56
-0.40%
MMSI Merit Medical Systems, Inc.
72.03
+1.46%
BAX Baxter International Inc.
39.47
-0.45%
COO The Cooper Companies, Inc.
90.42
+0.01%
XRAY DENTSPLY SIRONA Inc.
30.50
+0.20%
ALC Alcon Inc.
79.55
+1.38%
ICUI ICU Medical, Inc.
95.77
-1.17%
UTMD Utah Medical Products, Inc.
68.58
+2.01%
HAE Haemonetics Corporation
81.24
-2.66%